Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need to take a ...

Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research ...

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Danaher, with a price target of $250.00. The company’s shares closed yesterday at $189.91. Take advantage of ...

If an investor was to purchase shares of DHR stock at the current price level of $183.91/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

The stock's fall snapped a two-day winning streak.

We just received data on a new analyst forecast for $DHR. Dan Leonard from UBS set a price target of 240.0 for DHR.

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Danaher (NYSE:DHR – Get Free Report) had its target price boosted by research analysts at Barclays from $205.00 to $215.00 in a report issued on Tuesday,Benzinga reports.

This was the stock's third consecutive day of losses.